Celosia Therapeutics
Sydney
About Celosia Therapeutics
The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $18.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2024)
- Website: celosiatx.com
- Phone: +61 2 9850 2877
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/celosia-therapeutics-154155 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.